ReviewInternational journal of reproductive biomedicine2018
The prevalence of menstrual disorders in Iran: A systematic review and meta-analysis.
Review in International journal of reproductive biomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Prevalence of menstrual disturbances and associated factors among female medical students in Southeast Asia: a systematic review and meta-analysis.BMC women's health · 2026Pooled it
- Burden, impacts and management practices of dysmenorrhea among female students in Ethiopia: a systematic review and meta-analysis.International health · 2025Pooled it
- COVID-19 vaccination and menstrual disorders among women: Findings from a meta-analysis study.Journal of infection and public health · 2023Pooled it
- The impact of omega-3 polyunsaturated fatty acids on primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials.European journal of clinical pharmacology · 2022Pooled it
- A systematic review of the menstrual experiences of university students and the impacts on their education: A global perspective.PloS one · 2021Pooled it
- Prevalence of dysmenorrhea and associated factors among students in Ethiopia: A systematic review and meta-analysis.Women's health (London, England)Pooled it
- The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial.BMC women's health · 2023Trial
- Review
- Impact of Dysmenorrhea Severity on Mental Wellbeing and Quality of Life Among Saudi Women: A Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2025Article
- Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women's health in the Middle East and Africa.BMC women's health · 2025Review
- Article
- Double stigma of menstruation and premenstrual disorders for middle eastern women.Archives of public health = Archives belges de sante publique · 2025Article
- Exploring the molecular mechanism ofHeliyon · 2025Article
- Changes in menstrual cycles among Iranian women during the COVID-19 pandemic: A cross-sectional study.International journal of reproductive biomedicine · 2024Article
- Prevalence, pain intensity and symptoms associated with primary dysmenorrhea: a cross-sectional study.BMC women's health · 2024Article
- Assessment of COVID-19 Vaccine Impact on Women's Menstrual Health within an 18-Month Follow-Up.Obstetrics and gynecology international · 2024Article
- Biology of Anemia: A Public Health Perspective.The Journal of nutrition · 2023Article
- Approaches to Address the Anemia Challenge.The Journal of nutrition · 2023Article
- Prevalence of heavy menstrual bleeding and associations with physical health and wellbeing in low-income and middle-income countries: a multinational cross-sectional study.The Lancet. Global health · 2023Article
- Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health Study.American journal of obstetrics and gynecology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding the prevalence of menstrual disorders has important implications for both health service planning and risk factor epidemiology.
objectiveThe aim of this review is to identify and collate studies describing the prevalence of menstrual disorders in Iran. MATERIALS AND
methodsStudies with original data related to the prevalence of menstrual disorders were identified via searching six electronic databases and reviewing citations. All abstracts or titles found by the electronic searches were independently scrutinized by two reviewers. The Meta-analysis was performed with a random effects model, considering the remarkable heterogeneity among studies. A total of 35 eligible epidemiological studies were included in this review.
resultsOverall, the pooled prevalence of primary dysmenorrhea was 73.27% (95% CI=65.12-81.42). The mean proportion of women with oligomenorrhea was 13.11% (95.5%, 95% CI: 10.04-16.19). We identified 16 studies that reported polymenorrhoea with a random effect of pooled prevalence estimate of 9.94% (95% CI 7.33%-12.56%). The prevalence estimate of hypermenorrhea was 12.94% (95% CI 9.31%-16.57%). Overall prevalence of hypomenorrhea was 5.25% (95% CI 3.20%-7.30%), ranging from 0.9- 12.90%. Pooling six studies that reported estimates for menorrhagia, the overall prevalence was 19.24% (95% CI 12.78-25.69). Overall, 6.04% (95% CI: 1.99-10.08) of the women were shown to have metrorrhagia.
conclusionThis systematic review suggests that the average prevalence of menstrual disorders in Iran is substantial. It has been neglected as a fundamental problem of women's reproductive health. Diagnosis and treatment of these disorders should be included in the primary health care system of reproductive health.
Indexed as
Identifiers
30775681PMC6350848What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.